Press "Enter" to skip to content

Posts tagged as “the Supreme Court”

Biden Administration Asks Supreme Court to Intervene in Emergency Dispute Over Texas Judge’s Ruling on Medication Abortion Drug

The Biden administration has asked the Supreme Court to intervene in an emergency dispute over a Texas judge's ruling which prevents pregnant women from obtaining the key abortion drug mifepristone by mail. The Justice Department argues that the ruling countermands the FDA's scientific judgment and would make it more difficult for women to access the drug, particularly in rural areas. The Supreme Court has yet to respond to the motion, which if accepted, would put the lower court ruling on hold and allow women to continue to access the drug by mail.

Harlan Crow’s Real Estate Company Purchases Properties from Supreme Court Justice Clarence Thomas, Raising Questions of Potential Conflicts of Interest

Harlan Crow, a prominent Republican donor and vocal supporter of President Donald Trump, recently purchased a single-story home and two vacant lots in Savannah, Georgia from Supreme Court Justice Clarence Thomas, his mother, and the family of Thomas' late brother. This marks the first known instance of money flowing from Crow to Thomas, and raises questions about their relationship and potential conflicts of interest, though the Supreme Court has yet to comment on the purchase.

Justice Department to Appeal to Supreme Court After Fifth Circuit Court Reimposes Restrictions on Abortion Pill Mifepristone

The Justice Department has announced plans to appeal to the Supreme Court after the Fifth Circuit Court of Appeals reimposed restrictions on mifepristone, commonly known as the abortion pill. Attorney General Merrick Garland said the Justice Department "strongly disagrees" with the court's decision and will be asking the Supreme Court to intervene. The FDA's decision to lift restrictions on mifepristone had been welcomed by abortion rights advocates, and the Supreme Court's decision on the case could have a major impact on the availability of the drug.

Appeals Court Partially Grants Request to Freeze Texas Judge’s Order Limiting Access to Mifepristone Abortion Drug

A federal appeals court has partially granted a request to freeze parts of a Texas judge’s order that would have suspended the US Food and Drug Administration’s approval of a medication abortion drug, mifepristone. The court’s order will keep the approval in effect and the drug on the market while an expedited appeal plays out, but under tighter rules that would allow the drug only to be dispensed up to seven weeks, not 10, and not by mail. The decision is expected to be appealed to the Supreme Court.

U.S. District Judge’s Ruling to Stay FDA Approval of Abortion Drug Mifepristone Likely to Reach Supreme Court

A federal judge has issued a ruling to stay the FDA's approval of the abortion drug mifepristone, in response to a lawsuit brought by anti-abortion groups in Texas. The ruling invalidates the FDA's 23-year-old approval of the drug, and the groups have urged the 5th U.S. Circuit Court of Appeals to let the ruling stand. The case is likely to be taken to the Supreme Court, and the outcome could have a significant impact on access to the medication.

Senate Judiciary Committee Urges Supreme Court Chief Justice John Roberts to Investigate Justice Clarence Thomas’ Acceptance of Lavish Gifts and Luxury Travel from Billionaire GOP Megadonor

The Senate Judiciary Committee has called on Supreme Court Chief Justice John Roberts to investigate Justice Clarence Thomas for failing to disclose 20 years' worth of lavish gifts and luxury travel from a GOP megadonor. The Committee, chaired by Dick Durbin, is also planning to hold a hearing on the need to restore public confidence in the Supreme Court. The ProPublica report revealed that Thomas had failed to disclose the gifts and trips as required by law, sparking the latest development in a long-running controversy surrounding the Supreme Court's ethics standards.

We've updated the design to something a little more modern.  Got an opinion?  Let us know!